AstraZeneca PLC
Last updated September 27, 2026
Organization details
- Legal name
- AstraZeneca PLC
- Former names
- Zeneca Group PLC
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Year founded
- 1992
- Jurisdiction of incorporation
- United Kingdom
- Headquarters city
- Cambridge
- Headquarters country
- United Kingdom
- Fiscal year end
- December
- Ticker symbol
- AZN
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0000901832
- UK company number
- 02723534
- Wikidata ID
- Q731938
Board of directors
-
Anna Olive Magdelene Manz · DirectorSince 2023
-
Aradhana Sarin · DirectorSince 2021
-
Birgit Conix · DirectorSince 2025
-
Diana Louise Patricia Layfield · DirectorSince 2020
-
Euan Angus Ashley · DirectorSince 2020
-
Karen Elizabeth Knudsen Costello · DirectorSince 2025
-
Marcus Wallenberg · DirectorSince 1999
-
Michel Roger Demare · DirectorSince 2019
-
Pascal Claude Roland Soriot · DirectorSince 2012
-
Philip Arthur John Broadley · DirectorSince 2017
-
Sherilyn Dawn McCoy · DirectorSince 2017
-
Tony Shu Kam Mok · DirectorSince 2019
-
Wan Ling Martello · DirectorSince 2026
Former directors
-
Andreas Rummelt · Director2021 – 2025
-
Ann Cairns · Director2014 – 2017
-
Cornelia Isabella, Bargmann · Director2015 – 2016
-
Deborah Disanzo Eldracher · Director2017 – 2025
-
Donald Bruce, Burlington · Director2010 – 2017
-
Genevieve Bernadette, Berger · Director2012 – 2021
-
Graham Chipchase · Director2012 – 2021
-
Jean-Philippe Courtois · Director2008 – 2016
-
John Varley · Director2006 – 2015
-
Leif Valdemar Johansson · Director2012 – 2023
-
Marc Pierre Jean Dunoyer · Director2013 – 2021
-
Nancy Jane, Rothwell · Director2006 – 2015
-
Rene Anthony Andrada Haas · Director2025 – 2026
-
Rudolph Harold Peter Markham · Director2008 – 2019
-
Sabera Nazneen Rahman · Director2017 – 2026
-
Shriti, Vadera · Director2011 – 2018
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $3,249
- 1 purchase by 1 insider
- Sold, last 12 months
- $2,209,482
- 1 sale by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 8, 2026 | Sharma Mani Officer (See Remarks) | Grant or award | +1 | $162.60 | $163 |
| Aug 8, 2026 | Sharma Mani Officer (See Remarks) | Open-market purchase | +20 | $160.57 | $3,249 |
| Aug 6, 2026 | Sharma Mani Officer (SVP, Group Controller) | Grant or award | +2 | $163.34 | $327 |
| Jul 6, 2026 | Sharma Mani Officer (See Remarks) | Grant or award | +2 | $190.43 | $381 |
| Jun 8, 2026 | Sharma Mani Officer (See Remarks) | Grant or award | +1 | $179.75 | $180 |
| May 20, 2026 | Sharma Mani Officer (See Remarks) | Open-market sale | −11,893 | $185.78 | $2,209,482 |
| May 6, 2026 | Sharma Mani Officer (See Remarks) | Grant or award | +1 | $186.28 | $186 |
| Apr 7, 2026 | Sharma Mani Officer (See Remarks) | Grant or award | +1 | $196.03 | $196 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.